Evidence map›Paper›PMID 26382241›Full record

ArticleLancet (London, England)2015

Changes in health in England, with analysis by English regions and areas of deprivation, 1990-2013: a systematic analysis for the Global Burden of Disease Study 2013.

John N Newton, Adam D M Briggs, Christopher J L Murray, Daniel Dicker, Kyle J Foreman, Haidong Wang, Mohsen Naghavi, Mohammad H Forouzanfar, Summer Lockett Ohno, Ryan M Barber and 67 more

Abstract read
In one paragraph

Article in Lancet (London, England), 2015. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 149 papers, 10 of them syntheses that pooled it.

0numbers the graph read from it
0cells of the map it votes in
149citing papers in PubMed, 10 pooled it
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

149 citing papers in PubMed, 10 syntheses or guidelines pooled it.

  1. Pooled it
  2. Pooled it
  3. Pooled it
  4. Pooled it
  5. Pooled it
  6. Pooled it
  7. Pooled it
  8. Pooled it
  9. Pooled it
  10. Pooled it
  11. Trial
  12. Trial
  13. Trial
  14. Impact of calorie labelling in worksite cafeterias: a stepped wedge randomised controlled pilot trial.The international journal of behavioral nutrition and physical activity · 2018
    Trial
  15. Trial
  16. Trial
  17. Trial
  18. Global burden of subarachnoid hemorrhage in young adults, 1990-2021: disparities, risk factors, and projections to 2050.Neurological sciences : official journal of the Italian Neurological Society and of the Italian Society of Clinical Neurophysiology · 2026
    Article
  19. Article
  20. Article

89 more citing papers are in PubMed but not listed here.

4 · The record

Corrections and comments

5 · Who and what money

Authors and funding

77 authors.

John N NewtonPublic Health England, London, UK; University of Manchester, Manchester, UK. Electronic address: john.newton@phe.gov.uk.
Adam D M BriggsUniversity of Oxford, Oxford, UK.
Christopher J L MurrayInstitute for Health Metrics and Evaluation, Seattle, WA, USA.
Daniel DickerInstitute for Health Metrics and Evaluation, Seattle, WA, USA.
Kyle J ForemanInstitute for Health Metrics and Evaluation, Seattle, WA, USA.
Haidong WangInstitute for Health Metrics and Evaluation, Seattle, WA, USA.
Mohsen NaghaviInstitute for Health Metrics and Evaluation, Seattle, WA, USA.
Mohammad H ForouzanfarInstitute for Health Metrics and Evaluation, Seattle, WA, USA.
Summer Lockett OhnoInstitute for Health Metrics and Evaluation, Seattle, WA, USA.
Ryan M BarberInstitute for Health Metrics and Evaluation, Seattle, WA, USA.
Theo VosInstitute for Health Metrics and Evaluation, Seattle, WA, USA.
Jeffrey D StanawayInstitute for Health Metrics and Evaluation, Seattle, WA, USA.
Jürgen C SchmidtPublic Health England, London, UK.
Andrew J HughesPublic Health England, London, UK.
Derek F J FayPublic Health England, London, UK.
Russell EcobPublic Health England, London, UK.
Charis GresserPublic Health England, London, UK.
Martin McKeeDepartment of Health Services Research and Policy, London School of Hygiene & Tropical Medicine, London, UK.
Harry RutterLondon School of Hygiene & Tropical Medicine, Oxford Martin School, University of Oxford, Oxford, UK.
Ibrahim AbubakarPublic Health England, London, UK; Centre for Infectious Disease Epidemiology and MRC Clinical Trials Unit, London, UK.
Raghib AliINDOX Cancer Research Network, Oxford, UK; John Radcliffe Hospital, Oxford, UK; Green-Templeton College, University of Oxford, Oxford, UK.
H Ross AndersonPopulation Health Research Institute, Hamilton, ON, Canada; MRC-PHE Centre for Environment and Health, London, UK; St George's, University of London, London, UK.
Amitava BanerjeeUniversity of Birmingham, Birmingham, UK.
Derrick A BennettClinical Trials Service Unit and Epidemiological Studies Unit, Nuffield Department of Population Health, University of Oxford, Oxford, UK.
Eduardo BernabéKing's College London Dental Institute, London, UK.
Kamaldeep S BhuiWolfson Institute of Preventive Medicine, Barts & The London School of Medicine, Queen Mary University of London, London, UK.
Stanley M BiryukovInstitute for Health Metrics and Evaluation, Seattle, WA, USA.
Rupert R BourneVision & Eye Research Unit, Anglia Ruskin University, Cambridge, UK.
Carol E G BrayneCambridge Institute of Public Health, University of Cambridge, Cambridge, UK.
Nigel G BruceUniversity of Liverpool, Liverpool, UK.
Traolach S BrughaUniversity of Leicester, Leicester, UK.
Michael BurchGreat Ormond Street Hospital for Children, London, UK.
Simon CapewellUniversity of Liverpool, Liverpool, UK.
Daniel CaseyInstitute for Health Metrics and Evaluation, Seattle, WA, USA.
Rajiv ChowdhuryUniversity of Cambridge, Cambridge, UK.
Matthew M CoatesInstitute for Health Metrics and Evaluation, Seattle, WA, USA.
Cyrus CooperMRC Lifecourse Epidemiology Unit, University of Southampton, Southhampton, UK.
Julia A CritchleySt George's, University of London, London, UK.
Paul I DarganGuy's and St Thomas' NHS Foundation Trust, London, UK.
Mukesh K DheraniUniversity of Liverpool, Liverpool, UK.
Paul ElliottDepartment of Epidemiology and Biostatistics, MRC-PHE Centre for Environment and Health, Imperial College London, London, UK.
Majid EzzatiMRC-PHE Centre for Population Health, School of Public Health, Imperial College London, London, UK.
Kevin A FentonPublic Health England, London, UK.
Maya S FraserInstitute for Health Metrics and Evaluation, Seattle, WA, USA.
Thomas FürstDepartment of Infectious Disease Epidemiology, Imperial College London, London, UK.
Felix GreavesPublic Health England, London, UK; Department of Primary Care and Public Health, Imperial College London, London, UK.
Mark A GreenSchool of Health and Related Research (ScHARR), University of Sheffield, Sheffield, UK.
David J GunnellSchool of Social and Community Medicine, University of Bristol, Bristol, UK.
Bernadette M HanniganPublic Health England, London, UK; Ulster University, Coleraine, Northern Ireland.
Roderick J HayInternational Foundation for Dermatology, London, UK.
Simon I HayInstitute for Health Metrics and Evaluation, Seattle, WA, USA; Wellcome Trust Centre for Human Genetics, University of Oxford, Oxford, UK.
Harry HemingwayUniversity College London, London, UK; Farr Institute of Health Informatics Research, London, UK.
Heidi J LarsonInstitute for Health Metrics and Evaluation, Seattle, WA, USA; Department of Infectious Disease Epidemiology, London School of Hygiene & Tropical Medicine, London, UK.
Katharine J LookerSchool of Social and Community Medicine, University of Bristol, Bristol, UK.
Raimundas LuneviciusUniversity of Liverpool, Liverpool, UK; Aintree University Hospital NHS Foundation Trust, University of Liverpool, Liverpool, UK.
Ronan A LyonsFarr Institute, College of Medicine, Swansea University, Swansea, UK.
Wagner MarcenesQueen Mary University of London.
Amanda J Mason-JonesDepartment of Health Sciences, University of York, York, UK; Adolescent Health Research Unit, University of Cape Town, Cape Town, South Africa.
Fiona E MatthewsCambridge Institute of Public Health, University of Cambridge, Cambridge, UK; Institute of Health and Society, Newcastle University, Newcastle, UK.
Henrik MollerCancer Epidemiology and Population Health, King's College London, London, UK.
Michele E MurdochWest Hertfordshire Hospitals NHS Trust, Hertfordshire, UK.
Charles R NewtonUniversity of Oxford, Oxford, UK.
Neil PearceLondon School of Hygiene & Tropical Medicine, Oxford Martin School, University of Oxford, Oxford, UK.
Frédéric B PielUniversity of Oxford, Oxford, UK.
Daniel PopeUniversity of Liverpool, Liverpool, UK.
Kazem RahimiGeorge Institute for Global Health and Division of Cardiovascular Medicine, Oxford Martin School, University of Oxford, Oxford, UK.
Alina RodriguezDepartment of Epidemiology and Biostatistics, MRC-PHE Centre for Environment and Health, Imperial College London, London, UK; Mid Sweden University, Sundsvall, Sweden.
Peter ScarboroughBritish Heart Foundation Centre on Population Approaches for NCD Prevention, University of Oxford, Oxford, UK.
Austin E SchumacherInstitute for Health Metrics and Evaluation, Seattle, WA, USA.
Ivy ShiueUniversity of Edinburgh, Edinburgh, Scotland; Northumbria University, Newcastle upon Tyne.
Liam SmeethFarr Institute of Health Informatics Research, London, UK; London School of Hygiene & Tropical Medicine, Oxford Martin School, University of Oxford, Oxford, UK.
Alison TedstonePublic Health England, London, UK.
Jonathan ValabhjiNHS England, Leeds, UK; Imperial College Healthcare NHS Trust, London, UK; Imperial College London, London, UK.
Hywel C WilliamsUniversity of Nottingham, Nottingham, UK.
Charles D A WolfeKing's College London, London, UK.
Anthony D WoolfRoyal Cornwall Hospital, Treliske, UK.
Adrian C J DavisPublic Health England, London, UK; London School of Economics, London, UK; University College London, London, UK.

Funding

British Heart Foundation RG/08/014/24067Department of Health CDF-2013-06-012Department of Health RP-PG-0407-10184Medical Research Council G0400491Medical Research Council G0900847Medical Research Council MC_U147585819Medical Research Council MC_U147585824Medical Research Council MC_U147585827Medical Research Council MC_UP_A620_1014Medical Research Council MC_UU_12011/1Medical Research Council MR/K006525/1Medical Research Council MR/K006584/1Medical Research Council MR/K023233/1Medical Research Council MR/L003120/1Medical Research Council MR/L01341X/1Wellcome Trust 098504Wellcome Trust 100693
6 · The paper itself

Abstract

backgroundIn the Global Burden of Disease Study 2013 (GBD 2013), knowledge about health and its determinants has been integrated into a comparable framework to inform health policy. Outputs of this analysis are relevant to current policy questions in England and elsewhere, particularly on health inequalities. We use GBD 2013 data on mortality and causes of death, and disease and injury incidence and prevalence to analyse the burden of disease and injury in England as a whole, in English regions, and within each English region by deprivation quintile. We also assess disease and injury burden in England attributable to potentially preventable risk factors. England and the English regions are compared with the remaining constituent countries of the UK and with comparable countries in the European Union (EU) and beyond.

methodsWe extracted data from the GBD 2013 to compare mortality, causes of death, years of life lost (YLLs), years lived with a disability (YLDs), and disability-adjusted life-years (DALYs) in England, the UK, and 18 other countries (the first 15 EU members [apart from the UK] and Australia, Canada, Norway, and the USA [EU15+]). We extended elements of the analysis to English regions, and subregional areas defined by deprivation quintile (deprivation areas). We used data split by the nine English regions (corresponding to the European boundaries of the Nomenclature for Territorial Statistics level 1 [NUTS 1] regions), and by quintile groups within each English region according to deprivation, thereby making 45 regional deprivation areas. Deprivation quintiles were defined by area of residence ranked at national level by Index of Multiple Deprivation score, 2010. Burden due to various risk factors is described for England using new GBD methodology to estimate independent and overlapping attributable risk for five tiers of behavioural, metabolic, and environmental risk factors. We present results for 306 causes and 2337 sequelae, and 79 risks or risk clusters.

findingsBetween 1990 and 2013, life expectancy from birth in England increased by 5·4 years (95% uncertainty interval 5·0-5·8) from 75·9 years (75·9-76·0) to 81·3 years (80·9-81·7); gains were greater for men than for women. Rates of age-standardised YLLs reduced by 41·1% (38·3-43·6), whereas DALYs were reduced by 23·8% (20·9-27·1), and YLDs by 1·4% (0·1-2·8). For these measures, England ranked better than the UK and the EU15+ means. Between 1990 and 2013, the range in life expectancy among 45 regional deprivation areas remained 8·2 years for men and decreased from 7·2 years in 1990 to 6·9 years in 2013 for women. In 2013, the leading cause of YLLs was ischaemic heart disease, and the leading cause of DALYs was low back and neck pain. Known risk factors accounted for 39·6% (37·7-41·7) of DALYs; leading behavioural risk factors were suboptimal diet (10·8% [9·1-12·7]) and tobacco (10·7% [9·4-12·0]).

interpretationHealth in England is improving although substantial opportunities exist for further reductions in the burden of preventable disease. The gap in mortality rates between men and women has reduced, but marked health inequalities between the least deprived and most deprived areas remain. Declines in mortality have not been matched by similar declines in morbidity, resulting in people living longer with diseases. Health policies must therefore address the causes of ill health as well as those of premature mortality. Systematic action locally and nationally is needed to reduce risk exposures, support healthy behaviours, alleviate the severity of chronic disabling disorders, and mitigate the effects of socioeconomic deprivation.

fundingBill & Melinda Gates Foundation and Public Health England.

Indexed as

Health StatusPoverty AreasAgedAged, 80 and overCause of DeathEnglandFemaleHealth Status DisparitiesHumansIncidenceLife ExpectancyLife TablesMalePrevalenceRisk Factors

Identifiers

PMID26382241
PMCPMC4672153

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.